Results of the phase 2 cohort of lenvatinib (LEN) plus everolimus (EVE) in recurrent/refractory childhood solid tumors, performed in collaboration with the Children's Oncology Group Meeting Abstract


Authors: Dela Cruz, F.; Fox, E.; Dubois, S.; Friedman, G.; Croop, J.; Kim, A.; Morgenstern, D.; Balis, F.; Macy, M.; Pressey, J.; Watt, T.; Krystal, J.; Vo, K.; Mody, R.; Laetsch, T.; Weigel, B.; O'Hara, K.; Okpara, C.; He, C.; Bender, J.
Abstract Title: Results of the phase 2 cohort of lenvatinib (LEN) plus everolimus (EVE) in recurrent/refractory childhood solid tumors, performed in collaboration with the Children's Oncology Group
Meeting Title: 55th Congress of the International Society of Paediatric Oncology (SIOP)
Journal Title: Pediatric Blood and Cancer
Volume: 70
Issue: Suppl. 8
Meeting Dates: 2023 Oct 11-14
Meeting Location: Ottawa, Canada
ISSN: 1545-5009
Publisher: Wiley Periodicals, Inc  
Date Published: 2023-11-01
Start Page: e30748
Language: English
ACCESSION: WOS:001183650901285
PROVIDER: wos
DOI: 10.1002/pbc.30748
Notes: Meeting Abstract: EP373/#178 - "Poster Topic: AS05 SIOP Scientific Program/AS05.h Soft Tissue Sarcomas" -- Located on pages S332-S333 of PDF -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors